JM, G., DF, F., P, S., NO, S., R, C., S, B., . . . J, D. (2017). Genetic invalidation of Lp-PLA2 as a therapeutic target: Large-scale study of five functional Lp-PLA2-lowering alleles. European journal of preventive cardiology, 24(5), 492. https://doi.org/10.1177/2047487316682186
Chicago Style (17th ed.) CitationJM, Gregson, et al. "Genetic Invalidation of Lp-PLA2 as a Therapeutic Target: Large-scale Study of Five Functional Lp-PLA2-lowering Alleles." European Journal of Preventive Cardiology 24, no. 5 (2017): 492. https://doi.org/10.1177/2047487316682186.
MLA (9th ed.) CitationJM, Gregson, et al. "Genetic Invalidation of Lp-PLA2 as a Therapeutic Target: Large-scale Study of Five Functional Lp-PLA2-lowering Alleles." European Journal of Preventive Cardiology, vol. 24, no. 5, 2017, p. 492, https://doi.org/10.1177/2047487316682186.